JP2017522288A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017522288A5 JP2017522288A5 JP2016573587A JP2016573587A JP2017522288A5 JP 2017522288 A5 JP2017522288 A5 JP 2017522288A5 JP 2016573587 A JP2016573587 A JP 2016573587A JP 2016573587 A JP2016573587 A JP 2016573587A JP 2017522288 A5 JP2017522288 A5 JP 2017522288A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- subject
- bmdsc
- use according
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010051909 Endometrial atrophy Diseases 0.000 claims description 9
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims description 8
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims description 8
- 210000000685 uterine artery Anatomy 0.000 claims description 7
- 238000002617 apheresis Methods 0.000 claims description 5
- 210000001185 bone marrow Anatomy 0.000 claims description 5
- 210000005259 peripheral blood Anatomy 0.000 claims description 5
- 239000011886 peripheral blood Substances 0.000 claims description 5
- 210000002565 arteriole Anatomy 0.000 claims description 4
- 230000032692 embryo implantation Effects 0.000 claims description 4
- 230000001483 mobilizing effect Effects 0.000 claims description 4
- 230000003054 hormonal effect Effects 0.000 claims description 3
- 210000000130 stem cell Anatomy 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims 14
- 208000028685 Asherman syndrome Diseases 0.000 claims 2
- 208000002777 Gynatresia Diseases 0.000 claims 2
- 238000000034 method Methods 0.000 description 19
- 230000002357 endometrial effect Effects 0.000 description 6
- 230000008929 regeneration Effects 0.000 description 6
- 238000011069 regeneration method Methods 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 3
- 230000003836 peripheral circulation Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462013121P | 2014-06-17 | 2014-06-17 | |
| US62/013,121 | 2014-06-17 | ||
| PCT/IB2015/001715 WO2015193737A1 (en) | 2014-06-17 | 2015-06-05 | Stem cell therapy in endometrial pathologies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020102340A Division JP2020138984A (ja) | 2014-06-17 | 2020-06-12 | 子宮内膜病変における幹細胞治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017522288A JP2017522288A (ja) | 2017-08-10 |
| JP2017522288A5 true JP2017522288A5 (enExample) | 2018-07-12 |
| JP6920062B2 JP6920062B2 (ja) | 2021-08-18 |
Family
ID=54329860
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016573587A Active JP6920062B2 (ja) | 2014-06-17 | 2015-06-05 | 子宮内膜病変における幹細胞治療 |
| JP2020102340A Pending JP2020138984A (ja) | 2014-06-17 | 2020-06-12 | 子宮内膜病変における幹細胞治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020102340A Pending JP2020138984A (ja) | 2014-06-17 | 2020-06-12 | 子宮内膜病変における幹細胞治療 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US11129851B2 (enExample) |
| EP (3) | EP3158057B1 (enExample) |
| JP (2) | JP6920062B2 (enExample) |
| CN (2) | CN116747241A (enExample) |
| AU (1) | AU2015275798B2 (enExample) |
| BR (1) | BR112016029558A2 (enExample) |
| CA (1) | CA2952559C (enExample) |
| CY (2) | CY1122615T1 (enExample) |
| DK (2) | DK3158057T3 (enExample) |
| ES (3) | ES2983444T3 (enExample) |
| HR (3) | HRP20220419T1 (enExample) |
| HU (3) | HUE044823T2 (enExample) |
| LT (2) | LT3569697T (enExample) |
| MX (1) | MX377300B (enExample) |
| PL (3) | PL3158057T3 (enExample) |
| PT (2) | PT3569697T (enExample) |
| RS (3) | RS63093B1 (enExample) |
| RU (1) | RU2725006C2 (enExample) |
| SI (2) | SI3158057T1 (enExample) |
| SM (3) | SMT202200155T1 (enExample) |
| TR (1) | TR201910410T4 (enExample) |
| WO (1) | WO2015193737A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010010201A1 (es) | 2008-07-22 | 2010-01-28 | Equipo Ivi Investigacion Sl | Perfil de expresion genetica como marcador de la receptividad endometrial |
| AU2013273242B2 (en) | 2012-06-06 | 2019-04-11 | Fundacio Institut De Recerca Biomedica (Irb Barcelona) | Method for the diagnosis, prognosis and treatment of lung cancer metastasis |
| ES2906586T3 (es) | 2012-10-12 | 2022-04-19 | Inbiomotion Sl | Método para el diagnóstico, pronóstico y tratamiento de metástasis de cáncer de próstata |
| US10119171B2 (en) | 2012-10-12 | 2018-11-06 | Inbiomotion S.L. | Method for the diagnosis, prognosis and treatment of prostate cancer metastasis |
| US20160040247A1 (en) | 2013-03-15 | 2016-02-11 | Fundació Institut De Recerca Biomèdica (Irb Barcelona) | Method for the diagnosis, prognosis, and tratment of cancer metastasis |
| SMT202200155T1 (it) | 2014-06-17 | 2022-05-12 | Asherman Therapy S L | Terapia con cellule staminali in patologie endometriali |
| EP3474866A4 (en) * | 2016-06-23 | 2020-02-26 | Tithon Biotech, Inc. | CELLS EXPRESSING THE PARATHYROID HORMONE RECEPTOR 1 AND USES THEREOF |
| RU2699029C1 (ru) * | 2018-12-10 | 2019-09-03 | Частное образовательное учреждение дополнительного профессионального образования "Академия медицинского образования имени Федора Ивановича Иноземцева" (ЧОУ ДПО "Академия медицинского образования им. Ф.И. Иноземцева") | Способ использования мезенхимальных стволовых клеток для улучшения состояния рубца на матке |
| RU2741621C1 (ru) * | 2020-09-25 | 2021-01-28 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации | Способ лечения внутриматочных синехий |
| KR20230015832A (ko) | 2021-07-23 | 2023-01-31 | 차의과학대학교 산학협력단 | 분리된 미토콘드리아를 유효성분으로 포함하는 아셔만 증후군 예방 또는 치료용 약학 조성물 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2054197A1 (en) | 1989-05-05 | 1990-11-06 | Christopher O'neill | Fertility enhancement |
| US6979533B2 (en) | 1992-06-12 | 2005-12-27 | The Trustees Of The University Of Pennsylvania | Determination of endometrial receptivity toward embryo implantation |
| CA2203718A1 (en) | 1997-04-25 | 1998-10-25 | University Of British Columbia | Cadherin-11 as an indicator of viable pregnancy |
| IL127896A0 (en) | 1998-12-31 | 1999-10-28 | Gail Laster | A novel treatment for preeclampsia and related diseases |
| AU2001240096A1 (en) | 2000-03-08 | 2001-09-17 | Rebecca L. Dubowy | Methods of diagnosing and monitoring endometrial glandular development |
| EP1301195A2 (en) | 2000-05-24 | 2003-04-16 | Schering Aktiengesellschaft | Pharmaceutical use of fibulin-1 |
| US6780594B2 (en) | 2000-09-25 | 2004-08-24 | Schering Aktiengesellschaft | Method for in vitro diagnosis of endometriosis |
| AUPR673001A0 (en) | 2001-07-31 | 2001-08-23 | Prince Henry's Institute Of Medical Research | Pregnancy-related enzyme activity |
| DE10139874A1 (de) | 2001-08-10 | 2003-04-30 | Schering Ag | Humane Mater-Proteine |
| GB0201284D0 (en) | 2002-01-21 | 2002-03-06 | Isis Innovation | Screening methods for contraceptive and fertility agents |
| US20030186300A1 (en) | 2002-03-20 | 2003-10-02 | Ali Akoum | Methods and products for modulation of reproductive processes and for diagnosis, prognostication and treatment of related conditions |
| US20040005612A1 (en) | 2002-05-14 | 2004-01-08 | Giudice Linda C. | Endometrial genes in endometrial disorders |
| AU2003255355A1 (en) | 2002-08-02 | 2004-02-25 | Schering Aktiengesellschaft | Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy |
| DE10236405A1 (de) | 2002-08-02 | 2004-02-19 | Schering Ag | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie |
| AU2003303347A1 (en) | 2002-12-21 | 2004-07-22 | Universitat Leipzig | Method and means for determining specific conditions or changes in the uterine epithelium and in the epithelium of other organs |
| US20060286555A1 (en) | 2003-08-21 | 2006-12-21 | Van Beuningen Marinus G J | Microarray support for bioprobe synthesis |
| EP1670902A4 (en) | 2003-09-08 | 2008-05-07 | Univ Texas | METHOD AND COMPOSITION FOR ENHANCING i IN VITRO /i EMBRYO DEVELOPMENT BY SUPPLEMENTING CULTURE MEDIUM WITH PROSTAGLANDIN OR A PROSTAGLANDIN ANALOG |
| CN1863905A (zh) | 2003-09-08 | 2006-11-15 | 得克萨斯系统大学董事会 | 通过用前列腺素或前列腺素类似物补充培养基加强体外胚发育的方法以及组合物 |
| EP1711618B1 (en) | 2003-12-23 | 2010-08-04 | Mount Sinai Hospital Corporation | Methods for detecting markers associated with endometrial disease or phase |
| AU2005249504A1 (en) | 2004-05-28 | 2005-12-15 | Laboratoires Serono Sa | Use of IL-17 in the treatment of fertility-related disorders |
| US20090111140A1 (en) * | 2006-03-31 | 2009-04-30 | Koninklijke Philips Electronics N.V. | Systems and methods for cell measurement utilizing ultrashort t2* |
| JP2007278750A (ja) | 2006-04-04 | 2007-10-25 | Ono Pharmaceut Co Ltd | プロスタグランジン類及びその類縁体の定量方法 |
| US20120269774A1 (en) * | 2006-09-21 | 2012-10-25 | Medistem Laboratories, Inc | Allogeneic stem cell transplants in non-conditioned recipients |
| GB0703683D0 (en) * | 2007-02-26 | 2007-04-04 | Ark Therapeutics Ltd | The treatment of complications in pregnancy |
| US9259233B2 (en) * | 2007-04-06 | 2016-02-16 | Hologic, Inc. | Method and device for distending a gynecological cavity |
| US8673850B2 (en) | 2008-05-30 | 2014-03-18 | Institut De Recherches Cliniques De Montreal | PCSK9 inhibitors and methods of use thereof |
| WO2010010201A1 (es) | 2008-07-22 | 2010-01-28 | Equipo Ivi Investigacion Sl | Perfil de expresion genetica como marcador de la receptividad endometrial |
| WO2013166281A1 (en) * | 2012-05-02 | 2013-11-07 | Cedars-Sinai Medical Center | Bi-functional compositions for targeting cells to diseased tissues and methods of using same |
| EP2348318A1 (en) | 2010-01-21 | 2011-07-27 | Equipo Ivi Investigación, S.L. | Diagnostic method for endometrial receptivity |
| JP6204919B2 (ja) | 2011-10-21 | 2017-09-27 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 調節性過排卵誘起後の患者の子宮内膜受容性を評価するための方法 |
| AU2012346594B2 (en) | 2011-11-30 | 2017-12-21 | Agency For Science, Technology And Research | GM1 ganglioside to Annexin V microparticle polypeptide ratio for biological monitoring |
| WO2014001244A1 (en) | 2012-06-27 | 2014-01-03 | Roche Diagnostics Gmbh | MEANS AND METHODS APPLYING sFlt-1/PlGF OR ENDOGLIN/PlGF RATIO TO RULE-OUT ONSET OF PREECLAMPSIA WITHIN A CERTAIN TIME PERIOD |
| RU2515475C1 (ru) | 2012-11-15 | 2014-05-10 | Федеральное государственное бюджетное учреждение науки ИНСТИТУТ ЦИТОЛОГИИ РОССИЙСКОЙ АКАДЕМИИ НАУК | Способ стимуляции образования децидуальной оболочки эндометрия в эксперименте |
| JP6684263B2 (ja) | 2014-03-21 | 2020-04-22 | アイジェノミクス エセ．エレ． | 子癇前症の早期検出 |
| SMT202200155T1 (it) | 2014-06-17 | 2022-05-12 | Asherman Therapy S L | Terapia con cellule staminali in patologie endometriali |
-
2015
- 2015-06-05 SM SM20220155T patent/SMT202200155T1/it unknown
- 2015-06-05 BR BR112016029558A patent/BR112016029558A2/pt not_active Application Discontinuation
- 2015-06-05 AU AU2015275798A patent/AU2015275798B2/en active Active
- 2015-06-05 CN CN202310575540.1A patent/CN116747241A/zh active Pending
- 2015-06-05 HR HRP20220419TT patent/HRP20220419T1/hr unknown
- 2015-06-05 WO PCT/IB2015/001715 patent/WO2015193737A1/en not_active Ceased
- 2015-06-05 ES ES22150013T patent/ES2983444T3/es active Active
- 2015-06-05 RS RS20220339A patent/RS63093B1/sr unknown
- 2015-06-05 LT LTEP19169309.2T patent/LT3569697T/lt unknown
- 2015-06-05 PL PL15781411T patent/PL3158057T3/pl unknown
- 2015-06-05 HR HRP20191240 patent/HRP20191240T1/hr unknown
- 2015-06-05 HU HUE15781411 patent/HUE044823T2/hu unknown
- 2015-06-05 RS RS20240690A patent/RS65719B1/sr unknown
- 2015-06-05 US US15/318,825 patent/US11129851B2/en active Active
- 2015-06-05 RS RSP20190913 patent/RS59210B1/sr unknown
- 2015-06-05 SM SM20190400T patent/SMT201900400T1/it unknown
- 2015-06-05 ES ES15781411T patent/ES2736117T3/es active Active
- 2015-06-05 LT LTEP15781411.2T patent/LT3158057T/lt unknown
- 2015-06-05 EP EP15781411.2A patent/EP3158057B1/en active Active
- 2015-06-05 HU HUE19169309A patent/HUE058328T2/hu unknown
- 2015-06-05 EP EP22150013.5A patent/EP4012023B1/en active Active
- 2015-06-05 JP JP2016573587A patent/JP6920062B2/ja active Active
- 2015-06-05 PT PT191693092T patent/PT3569697T/pt unknown
- 2015-06-05 SI SI201530822T patent/SI3158057T1/sl unknown
- 2015-06-05 HU HUE22150013A patent/HUE067463T2/hu unknown
- 2015-06-05 DK DK15781411.2T patent/DK3158057T3/da active
- 2015-06-05 CA CA2952559A patent/CA2952559C/en active Active
- 2015-06-05 SM SM20240270T patent/SMT202400270T1/it unknown
- 2015-06-05 TR TR2019/10410T patent/TR201910410T4/tr unknown
- 2015-06-05 PT PT15781411T patent/PT3158057T/pt unknown
- 2015-06-05 PL PL19169309T patent/PL3569697T3/pl unknown
- 2015-06-05 HR HRP20240798TT patent/HRP20240798T1/hr unknown
- 2015-06-05 EP EP19169309.2A patent/EP3569697B8/en active Active
- 2015-06-05 PL PL22150013.5T patent/PL4012023T3/pl unknown
- 2015-06-05 ES ES19169309T patent/ES2910306T3/es active Active
- 2015-06-05 DK DK19169309.2T patent/DK3569697T3/da active
- 2015-06-05 RU RU2017101147A patent/RU2725006C2/ru active
- 2015-06-05 SI SI201531822T patent/SI3569697T1/sl unknown
- 2015-06-05 CN CN201580043147.1A patent/CN107073040A/zh active Pending
- 2015-06-05 MX MX2016016756A patent/MX377300B/es active IP Right Grant
-
2019
- 2019-07-16 CY CY20191100753T patent/CY1122615T1/el unknown
-
2020
- 2020-06-12 JP JP2020102340A patent/JP2020138984A/ja active Pending
-
2022
- 2022-04-05 CY CY20221100258T patent/CY1125938T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017522288A5 (enExample) | ||
| JP2015131795A5 (enExample) | ||
| RU2017101147A (ru) | Терапия стволовыми клетками при патологиях эндометрия | |
| MX2025008493A (es) | Agentes de union a fibroblastos y uso de estos | |
| Terai et al. | Status of and candidates for cell therapy in liver cirrhosis: overcoming the “point of no return” in advanced liver cirrhosis | |
| EA201991692A1 (ru) | Иммуносконструированные плюрипотентные клетки | |
| WO2019032662A8 (en) | Clec9a binding agents and use thereof | |
| UY32668A (es) | Agentes inductores de la apoptosis para el tratamiento del cáncer y de enfermedades inmunes y autoinmunes | |
| MX2013004817A (es) | Enfermedad inflamatoria. | |
| Singhal et al. | Endothelial cell fitness dictates the source of regenerating liver vasculature | |
| PH12021552887A1 (en) | Modified viral particles and uses thereof | |
| EA201891931A1 (ru) | Новые ингибиторы фосфатидилинозитол-3-киназы гамма | |
| Galipeau | Mesenchymal stromal cells for graft-versus-host disease: a trilogy | |
| MY178445A (en) | Novel antibody binding to tfpi and composition comprising the same | |
| JP2017507145A5 (enExample) | ||
| Kim et al. | Pharmacoeconomic impact of up-front use of plerixafor for autologous stem cell mobilization in patients with multiple myeloma | |
| CN111770924A (zh) | 用于治疗乳腺癌的雌激素受体降解剂 | |
| WO2016066722A3 (en) | Bacteriophage combinations for human or animal therapy | |
| WO2019055776A3 (en) | Compositions and methods for treatment of diseases involving cxcl1 function | |
| MX2016004209A (es) | Terapia con celulas de placenta humana y celulas hematopoyeticas. | |
| NZ702666A (en) | A method of weight reduction | |
| King et al. | Bone marrow stem cell therapy for liver disease | |
| JP2018509479A5 (enExample) | ||
| Salem et al. | Vascular Complications after Adult to Adult Living Donor Liver Transplantation: Single Center Experience.: Abstract# P-704 | |
| Rodriguez | Interferon-α |